Tuvusertib (M1774) Human Mass Balance and Absolute Bioavailability Study (DDRIVER Solid Tumors 303)
Clinical trial NCT06308263 · COMPLETED
Trial details
- NCT number
- NCT06308263
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-25
- Primary completion
- 2026-04-14
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.